These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2303274)

  • 21. Further considerations of the "single-point single-dose" method to estimate individual maintenance dosage requirements.
    Unadkat JD; Rowland M
    Ther Drug Monit; 1982; 4(2):201-8. PubMed ID: 7101388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1990 Jun; 7(6):628-32. PubMed ID: 2367330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New developments in using stochastic recipe for multi-compartment model: inter-compartment traveling route, residence time, and exponential convolution expansion.
    Zhao L
    Math Biosci Eng; 2009 Jul; 6(3):663-82. PubMed ID: 19566134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some considerations on the design of population pharmacokinetic studies.
    Duffull S; Waterhouse T; Eccleston J
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):441-57. PubMed ID: 16284917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect.
    Klockowski PM; Levy G
    J Pharm Sci; 1987 Jul; 76(7):516-20. PubMed ID: 3668811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of infusion rates: computer study.
    Harrison MJ
    Br J Anaesth; 1990 Mar; 64(3):283-6. PubMed ID: 2328176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal.
    Wijnand HP
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):109-28. PubMed ID: 3373416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to avoid unbounded drug accumulation with fractional pharmacokinetics.
    Hennion M; Hanert E
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):691-700. PubMed ID: 24233541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fitting a general sigmoid model to pharmacological response curves [proceedings].
    Davey A; Marriott A; Stockham MA
    Br J Pharmacol; 1976 Oct; 58(2):289P-290P. PubMed ID: 974407
    [No Abstract]   [Full Text] [Related]  

  • 31. Expert Discussion of the Role of Rate Constant Versus Clearance Approaches to Define Drug Pharmacokinetics: Theoretical and Clinical Considerations.
    Martinez MN; Jelliffe RW; Proost JH
    AAPS J; 2020 Jan; 22(2):25. PubMed ID: 31907706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose response evaluation. Use of plasma concentration confidence intervals as a tool to predict optimal drug dose ratio.
    Lønning PE
    Clin Pharmacokinet; 1993 Jul; 25(1):1-5. PubMed ID: 8354015
    [No Abstract]   [Full Text] [Related]  

  • 33. Simplified derivation of Chiou-Hsu equation for rapid estimation of total body drug clearance during constant-rate intravenous infusion.
    Chiou WL
    J Pharm Sci; 1978 Dec; 67(12):1776-7. PubMed ID: 722504
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintenance-dose prediction based on a single determination of concentration: dose of parent drug required to give a desired steady-state concentration of metabolite.
    Wilson JM; Slattery JT
    J Pharm Sci; 1983 Oct; 72(10):1174-8. PubMed ID: 6644567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constant pharmacologic effect and chronopharmacology: theoretical aspects.
    Hecquet B
    Chronobiol Int; 1986; 3(3):149-54. PubMed ID: 3677197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A three compartment open model with two time lags.
    Cherruault Y; Sarin VB
    Int J Biomed Comput; 1993 May; 32(3-4):269-77. PubMed ID: 8514441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite.
    Bayne WF; Hwang SS
    J Pharm Sci; 1985 Jul; 74(7):722-6. PubMed ID: 4032242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-point maintenance dose prediction: role of interindividual differences in clearance and volume of distribution in choice of sampling time.
    Slattery JT
    J Pharm Sci; 1981 Oct; 70(10):1174-6. PubMed ID: 7299658
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficiency of drug targeting: steady-state considerations using a three-compartment model.
    Boddy A; Aarons L; Petrak K
    Pharm Res; 1989 May; 6(5):367-72. PubMed ID: 2748526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cycle-time and residence-time density approximations in a stochastic model for circulatory transport.
    Smith CE; Lánský P; Lung TH
    Bull Math Biol; 1997 Jan; 59(1):1-22. PubMed ID: 8980303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.